Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Studies show slowing of UK life expectancy after financial crisis

Increases in life expectancy in the UK and elsewhere had slowed even before 2016 - and COVID-19 is expected to further eliminate any gains, Newcastle University studies show.

1 Feb 2021

India’s COVID-19-related hygiene promotion campaign shows some positive results

A new study explores the results of such hygiene promotion campaigns on handwashing practices in rural Odisha, India.

1 Feb 2021

Can metformin reduce mortality in diabetic individuals with severe COVID-19?

A new study by researchers in China and the U.S. describes a round-up of the effects of commonly used hypoglycemic drugs on the outcomes of COVID-19 in diabetic patients.

1 Feb 2021

Colchicine may have therapeutic potential against COVID-19

A new study describes the results of colchicine in mitigating the inflammatory storm associated with COVID-19, and thus preventing a percentage of severe and critical cases.

1 Feb 2021

Sepha Launches Small Batch Contract Packaging Service

Sepha, the Northern Ireland based specialist in pharmaceutical packaging and machinery, has launched a contract packaging service to meet rising demand for small batch production.

1 Feb 2021

How a bounty of vaccines flooded a small hospital and its nearby college

When administrators at Hillsdale College, a conservative liberal-arts school in Michigan, heard its local hospital didn't have a way to store the Pfizer-BioNTech covid vaccine, they offered the use of its science department's ultra-low temperature freezer. The vaccine must be stored at minus 94 degrees Fahrenheit.

1 Feb 2021

Inhaled single dose vaccine creates antibodies and prevents infection in rhesus macaques

Now, a new preprint research paper describes a chimpanzee adenovirus-vectored vaccine that, when administered intranasally in rhesus macaques, led to a robust immune response and demonstrated protection against infection by the virus that causes COVID-19, namely, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The preprint is published on the bioRxiv server.

1 Feb 2021

Complication of severe SARS-CoV-2 pneumonia results in persistent cortical blindness: Case report

A study recently published in the journal Cureus has described a case report of a coronavirus disease 2019 (COVID-19) patient who presented with pneumonia, posterior reversible encephalopathy syndrome (PRES), and persistent cortical blindness. A detailed clinical presentation of the patient is provided in the report.

31 Jan 2021

E484K mutation is potentially associated with SARS-CoV-2 adaptive fitness

A team of Brazilian scientists has recently conducted genomic and phylogenetic analyses of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genome to understand the viral evolution process better. Their analyses reveal that the E484K mutated variant of SARS-CoV-2 is present in three different lineages in four Brazilian regions and that the mutation may serve as a common solution for viral evolution.

31 Jan 2021

DSMB recommends continuation of Phase 2/3 study of opaganib for severe COVID-19

RedHill Biopharma Ltd., a specialty biopharmaceutical company, today announced that the independent Data Safety Monitoring Board (DSMB) for the global Phase 2/3 study of opaganib in patients with severe COVID-19, unanimously recommended to continue the study following a pre-scheduled futility review of unblinded efficacy data from the first 135 patients treated in the study and safety data from the first 175 patients.

30 Jan 2021

Research identifies and explores the impacts of emergent COVID-19 behavioral identities

New research by Mimi E. Lam (University of Bergen) just published in Humanities and Social Sciences Communications identifies and explores the impacts of salient viral or COVID-19 behavioural identities that are emerging.

30 Jan 2021

Survey: More than a third of Americans either unlikely or unsure to get a COVID-19 vaccine

News reports indicate COVID-19 vaccines are not getting out soon enough nor in adequate supplies to most regions, but there may be a larger underlying problem than shortages. A University of California, Davis, study found that more than a third of people nationwide are either unlikely or at least hesitant to get a COVID-19 vaccine when it becomes available to them.

30 Jan 2021

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Studies show slowing of UK life expectancy after financial crisis

India’s COVID-19-related hygiene promotion campaign shows some positive results

Can metformin reduce mortality in diabetic individuals with severe COVID-19?

Colchicine may have therapeutic potential against COVID-19

Sepha Launches Small Batch Contract Packaging Service

How a bounty of vaccines flooded a small hospital and its nearby college

Inhaled single dose vaccine creates antibodies and prevents infection in rhesus macaques

Complication of severe SARS-CoV-2 pneumonia results in persistent cortical blindness: Case report

E484K mutation is potentially associated with SARS-CoV-2 adaptive fitness

DSMB recommends continuation of Phase 2/3 study of opaganib for severe COVID-19

Research identifies and explores the impacts of emergent COVID-19 behavioral identities

Survey: More than a third of Americans either unlikely or unsure to get a COVID-19 vaccine

New forecasts show possibility of spike in COVID-19 cases and deaths in the spring

Traditional performing arts help tackle diarrhea in rural Gambia

Researchers explore adaptive immunity against human coronaviruses

Study finds surprising defensive functions of the immune system against new viral attacks

New gene-based vaccine strategy receives grant from the Bill & Melinda Gates Foundation

Pandemic sends a couple into indefinite long distance though just miles apart

New study explores the impacts of emerging "COVID-19 behavioral identities"

Vaccination chaos fuels push to recall Newsom

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Exploring electron microscopy for plant and microbial imaging at the John Innes Centre

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Exploring electron microscopy for plant and microbial imaging at the John Innes Centre

Newsletters you may be interested in